Home

Abbott Laboratories (ABT)

128.81
0.00 (0.00%)

Abbott Laboratories is a global healthcare company that specializes in the development of a wide range of medical devices, diagnostics, nutrition products, and pharmaceuticals

The company focuses on innovation to improve patient outcomes and enhance the quality of life for individuals worldwide. Abbott is known for its advancements in areas such as cardiovascular care, diabetes management, and nutrition science, providing essential tools and solutions that support healthcare professionals and patients in managing various health conditions. With a strong commitment to research and development, Abbott continually seeks to address unmet medical needs and contribute to the advancement of healthcare globally.

SummaryNewsPress ReleasesChartHistoricalFAQ
9 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · January 28, 2025
This Is What Whales Are Betting On Abbott Laboratoriesbenzinga.com
Via Benzinga · January 27, 2025
Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? 'Something May Be Wrong Here'benzinga.com
Cramer takes a look at TETRA Technologies, Abbott, Wendy's, Nu Holdings and Casella Waste on the latest edition of "Mad Money."
Via Benzinga · January 27, 2025
Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Mondaybenzinga.com
Via Benzinga · January 27, 2025
Market Whales and Their Recent Bets on ABT Optionsbenzinga.com
Via Benzinga · January 24, 2025
Deep Dive Into Abbott Laboratories Stock: Analyst Perspectives (6 Ratings)benzinga.com
Via Benzinga · January 23, 2025
Abbott Laboratories Will Outperform Healthcare Stocks in 2025
Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.
Via MarketBeat · January 24, 2025
My Top 5 Stocks to Buy in Early 2025fool.com
Via The Motley Fool · January 23, 2025
Why Is Abbott Stock Trading Higher On Thursday?benzinga.com
Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes Care and Medical Devices.
Via Benzinga · January 23, 2025
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcriptfool.com
ABT earnings call for the period ending December 31, 2024.
Via The Motley Fool · January 22, 2025
Congressional Trading Report: Rep. Thomas Kean Bought Over $1K In Abbott Laboratories Stockbenzinga.com
Via Benzinga · January 23, 2025
US Stock Futures Trade Mixed After Skirting Record Highs In Last Session: GE Aerospace, American Airlines, Union Pacific In Focusbenzinga.com
U.S. stock futures were mixed on Thursday following Wednesday's rally. Futures of benchmark indices were lower except Dow Jones.
Via Benzinga · January 23, 2025
S&P 500 Hits New Record As Netflix Reports Strong Results: Investor Sentiment Improves But Greed Index Remains In 'Fear' Zonebenzinga.com
Via Benzinga · January 23, 2025
Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profitinvestors.com
The company expects to earn an adjusted $5.05 to $5.25 per share this year, in line with forecasts for $5.16.
Via Investor's Business Daily · January 22, 2025
Got $1,500? 3 Healthcare Stocks to Buy and Hold Foreverfool.com
Via The Motley Fool · January 21, 2025
S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Runbenzinga.com
Market surges on AI Stargate initiative & strong earnings. S&P 500 hits record high of 6,100 points, led by tech giants & semiconductor stocks.
Via Benzinga · January 22, 2025
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Salesbenzinga.com
Via Benzinga · January 22, 2025
Chipmakers Rally On AI Stargate Bet, Netflix Soars, Bitcoin Falters As Trump Keeps Quiet On Crypto: What's Driving Markets Wednesday?benzinga.com
Tech stocks enjoyed a surge Wednesday, driven by a sharp rise in semiconductor shares after President Donald Trump, OpenAI's Sam Altman, Oracle Corp.
Via Benzinga · January 22, 2025
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fallbenzinga.com
Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong performance in medical devices.
Via Benzinga · January 22, 2025
US Stocks Likely To Open Higher As President Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watchbenzinga.com
U.S. stocks could open on a positive note on Wednesday, continuing to rally after Donald Trump's inauguration as the 47th President of the U.S. on Monday.
Via Benzinga · January 22, 2025
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.fool.com
Via The Motley Fool · January 21, 2025
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Foreverfool.com
Via The Motley Fool · January 21, 2025
Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zonebenzinga.com
The CNN Business Fear & Greed Index measures market sentiment, with higher fear putting pressure on stocks.
Via Benzinga · January 22, 2025
Earnings Scheduled For January 22, 2025benzinga.com
Via Benzinga · January 22, 2025
Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesdaybenzinga.com
Via Benzinga · January 22, 2025